In both cultured melanoma cells and tumors in vivo, AR gene silencing or treatment with AR inhibitors leads to chromosomal DNA breakage in the absence of other exogenous triggers, leakage into the cytoplasm, STING activation, and a STING-dependent pro-inflammatory cascade9. Here, STING1 is linked to melanoma.